Should Expectations about the Rate of New Antiretroviral Drug Development Impact the Timing of HIV Treatment Initiation and Expectations about Treatment Benefits?

• Amin Khademi,

  Affiliation Department of Industrial Engineering, Clemson University, Clemson, South Carolina, United States of America

  ⨯
• R. Scott Braithwaite,

  Affiliations Department of Medicine, New York University, New York City, New York, United States of America, Division of Comparative Effectiveness and Decision Sciences, Department of Population Health, NYU School of Medicine, New York City, New York, United States of America

  ⨯
• Denis Saure,

  Affiliation Department of Industrial Engineering, University of Chile, Santiago, RM, Chile

  ⨯
• Andrew J. Schaefer,

  Affiliation Department of Industrial Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Kimberly Nucifora,

  Affiliation Division of Comparative Effectiveness and Decision Sciences, Department of Population Health, NYU School of Medicine, New York City, New York, United States of America

  ⨯
• Mark S. Roberts

  * E-mail: mroberts@Pitt.edu

  Affiliations Department of Industrial Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯